Related Experiment Video

Updated: Jan 23, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.3K

Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy

E V Dementyeva1,2,3, S P Medvedev4,2,3,5, V R Kovalenko4,2,3,5

  • 1Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090, Russia. dementyeva@bionet.nsc.ru.

Biochemistry. Biokhimiia
|June 22, 2019
PubMed

Insights

Patient-specific induced pluripotent stem cells (iPSCs) model hypertrophic cardiomyopathy (HCM). This HCM model, derived from patient iPSCs with a MYBPC3 mutation, shows abnormal calcium handling, aiding disease mechanism studies.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Genetic Disease Modeling

Background:

  • Inherited cardiovascular diseases, like hypertrophic cardiomyopathy (HCM), lack effective therapies.
  • Patient-specific induced pluripotent stem cells (iPSCs) offer a novel approach to model these diseases.
  • Understanding HCM pathogenesis is crucial for developing targeted treatments.

Observation:

  • A hypertrophic cardiomyopathy patient with an R326Q mutation in the MYBPC3 gene was identified.
  • Patient-derived iPSCs were successfully generated and differentiated into cardiomyocytes.
  • Control iPSCs from a healthy donor were used for comparison.

Findings:

  • The patient's iPSC-derived cardiomyocytes displayed early signs of HCM.
  • Abnormal calcium handling was observed in the patient-derived cardiomyocytes.
  • Increased intracellular calcium concentration was a key feature in the disease model.

Implications:

  • Directed differentiation of patient iPSCs provides a valuable in vitro model for HCM.
  • This model facilitates the study of HCM pathogenesis and cellular mechanisms.
  • It paves the way for testing novel therapeutic strategies for hypertrophic cardiomyopathy.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K
The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells10:49

The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells

Published on: April 14, 2013

11.3K

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
440
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
502
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
490